Hiroshi Komazaki

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Ejection Fraction

Placebo Controlled

Patient Reported

Top Venues

The British journal of dermatology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroo Yokozeki, Hiroyuki Murota, Takayo Matsumura, Hiroshi Komazaki, null null
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years. The British journal of dermatology 191 (2) (2024)
Hiroo Yokozeki, Hiroyuki Murota, Takayo Matsumura, Hiroshi Komazaki, null null
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years. The British journal of dermatology 191 (2) (2024)
Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, Makoto Kawashima, null null
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial. Dermatology and therapy (2023)